Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
NBIX on Nasdaq
Kevin Charles Gorman - trading volume in the past year for Neurocrine Biosciences Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
515K |
$65.1M |
$126.41 |
Aug 7, 2025 |
Direct |
|
|
| Restricted Stock Unit |
16.8K |
$1.93M |
$115.04 |
Feb 13, 2025 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option |
0 |
$0 |
$73.60 |
Aug 7, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.